Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Protalix Drug in Phase IIa Study for Gaucher Disease
Protalix Drug in Phase IIa Study for Gaucher Disease
Protalix Drug in Phase IIa Study for Gaucher Disease
Submitted by
admin
on June 20, 2014 - 11:02am
Source:
Yahoo/Zacks.com
News Tags:
Protalix BioTherapeutics
Gaucher disease
PRX-112
Headline:
Protalix Drug in Phase IIa Study for Gaucher Disease
Do Not Allow Advertisers to Use My Personal information
